{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:40:39Z","timestamp":1772754039814,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402808"],"award-info":[{"award-number":["81402808"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1603101"],"award-info":[{"award-number":["U1603101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"12th Chinese Recruitment Program of Global Experts","award":["Thousand Talents Program"],"award-info":[{"award-number":["Thousand Talents Program"]}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2015354"],"award-info":[{"award-number":["2015354"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11030-018-9840-5","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T03:01:05Z","timestamp":1530586865000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Structural modification on rupestonic acid leads to highly potent inhibitors against influenza virus"],"prefix":"10.1007","volume":"23","author":[{"given":"Mamateli","family":"Obul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xincheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4652-6879","authenticated-orcid":false,"given":"Haji Akber","family":"Aisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5730-9549","authenticated-orcid":false,"given":"Guozheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"issue":"6","key":"9840_CR1","first-page":"648","volume":"17","author":"I Abdiryim","year":"2001","unstructured":"Abdiryim I, Halmurat (2001) An electron paramagnetic resonance study on the antioxidant effects of artemisia flavonoids. Chin Pharmacol Bull 17(6):648\u2013650","journal-title":"Chin Pharmacol Bull"},{"issue":"2","key":"9840_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.13865\/j.cnki.cjbmb.2001.02.020","volume":"17","author":"A Sirafil","year":"2001","unstructured":"Sirafil A, Ilhamjan X, Halmurat (2001) Regulation of p53, Fas and bcl-2 gene expressions with artemisia flavonoid in human hepatoma. Chin J Biochem Mol Biol 17(2):226\u2013229. \n                    https:\/\/doi.org\/10.13865\/j.cnki.cjbmb.2001.02.020","journal-title":"Chin J Biochem Mol Biol"},{"issue":"1","key":"9840_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.13684\/j.cnki.spkj.2011.01.071","volume":"36","author":"MZ Fang","year":"2011","unstructured":"Fang MZ, Chao QF, Lan Y, Liu XN, Xin XU, Fan YH (2011) Antibacterial effect of the extract from Artemisia rupestris L. Food Sci Technol 36(1):160\u2013166. \n                    https:\/\/doi.org\/10.13684\/j.cnki.spkj.2011.01.071","journal-title":"Food Sci Technol"},{"issue":"6","key":"9840_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.apsb.2017.05.006","volume":"7","author":"J Yin","year":"2017","unstructured":"Yin J, Ma L, Wang H, Yan H, Hu J, Jiang W, Li Y (2017) Chinese herbal medicine compound Yi-Zhi-Hao pellet inhibits replication of influenza virus infection through activation of heme oxygenase-1. Acta Pharm Sin B 7(6):630\u2013637. \n                    https:\/\/doi.org\/10.1016\/j.apsb.2017.05.006","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"9840_CR5","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/jssc.200700683","volume":"31","author":"Z Su","year":"2008","unstructured":"Su Z, Wu H, Yang Y, Aisa HA, Slukhan U, Aripova S (2008) Preparative isolation of guaipyridine sesquiterpene alkaloid from Artemisia rupestris L. flowers using high-speed counter-current chromatography. J Sep Sci 31(12):2161\u20132166. \n                    https:\/\/doi.org\/10.1002\/jssc.200700683","journal-title":"J Sep Sci"},{"key":"9840_CR6","doi-asserted-by":"publisher","unstructured":"Zhao Y, Su Z, Aisa HA (2009) 2-Phenoxychromone flavonoid glycoside from Artemisia rupestris. Chem Nat Compd 45(1):24\u201326. \n                    https:\/\/doi.org\/10.1007\/s10600-009-9218-0","DOI":"10.1007\/s10600-009-9218-0"},{"issue":"2","key":"9840_CR7","first-page":"122","volume":"23","author":"GS Xu","year":"1988","unstructured":"Xu GS, Chen XY, Yu DQ (1988) Rupestonic acid, a new sesquiterpene from Artemisia rupestris L. Acta Pharmacol Sin 23(2):122\u2013125","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"9840_CR8","first-page":"505","volume":"26","author":"GS Xu","year":"1991","unstructured":"Xu GS, Zhao W, Wu D, Yu DQ, He CH, Yang JJ, Sun F (1991) The structure and absolute configuration of isorupestonic acid from Artemisia rupestris L. Acta Pharmacol Sin 26(7):505\u2013509","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"9840_CR9","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.bmcl.2016.06.011","volume":"27","author":"G Li","year":"2017","unstructured":"Li G, Zhao J-Y, Niu C, Nie L-F, Dong C-Z, Aisa HA (2017) Structure\u2013activity relationship studies of 1-(1\u2032-hydroxyalkyl)rupestonic acid methyl esters against influenza viruses. Bioorg Med Chem Lett 27(6):1484\u20131487. \n                    https:\/\/doi.org\/10.1016\/j.bmcl.2016.06.011","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"9840_CR10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.5012\/bkcs.2011.32.4.1293","volume":"32","author":"J Yong","year":"2011","unstructured":"Yong J, Aisa HA (2011) Chemical modification of rupestonic acid and preliminarily in vitro antiviral activity against influenza A3 and B viruses. Bull Korean Chem Soc 32(4):1293\u20131297. \n                    https:\/\/doi.org\/10.5012\/bkcs.2011.32.4.1293","journal-title":"Bull Korean Chem Soc"},{"issue":"6","key":"9840_CR11","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.bmcl.2012.01.056","volume":"22","author":"J Zhao","year":"2012","unstructured":"Zhao J, Aisa HA (2012) Synthesis and anti-influenza activity of aminoalkyl rupestonates. Bioorg Med Chem Lett 22(6):2321\u20132325. \n                    https:\/\/doi.org\/10.1016\/j.bmcl.2012.01.056","journal-title":"Bioorg Med Chem Lett"},{"key":"9840_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.6023\/cjoc1108081","volume":"32","author":"J Zhao","year":"2012","unstructured":"Zhao J, Aisa HA (2012) Synthesis of novel isoxazole contained rupestonic acid derivatives and in vitro inhibitory activity against influenza viruses A and B. Chin J Org Chem 32:333\u2013337. \n                    https:\/\/doi.org\/10.6023\/cjoc1108081","journal-title":"Chin J Org Chem"},{"issue":"2","key":"9840_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2174\/138955713804805229","volume":"13","author":"J Yong","year":"2013","unstructured":"Yong J, Lu C, Aisa HA (2013) Advances in studies on the rupestonic acid derivatives as anti-influenza agents. Mini Rev Med Chem 13(2):310\u2013315. \n                    https:\/\/doi.org\/10.2174\/138955713804805229","journal-title":"Mini Rev Med Chem"},{"key":"9840_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejmech.2014.02.029","volume":"76","author":"Y-W He","year":"2014","unstructured":"He Y-W, Dong C-Z, Zhao J-Y, Ma L-L, Li Y-H, Aisa HA (2014) 1,2,3-Triazole-containing derivatives of rupestonic acid: click-chemical synthesis and antiviral activities against influenza viruses. Eur J Med Chem 76:245\u2013255. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2014.02.029","journal-title":"Eur J Med Chem"},{"issue":"2","key":"9840_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s10600-017-1970-y","volume":"53","author":"J Zhao","year":"2017","unstructured":"Zhao J, Niu C, Li G, Aisa HA (2017) Synthesis of rupestonic acid derivatives with antiviral activity. Chem Nat Compd 53(2):276\u2013283. \n                    https:\/\/doi.org\/10.1007\/s10600-017-1970-y","journal-title":"Chem Nat Compd"},{"key":"9840_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.freeradbiomed.2016.04.021","volume":"96","author":"L-L Ma","year":"2016","unstructured":"Ma L-L, Wang H-Q, Wu P, Hu J, Yin J-Q, Wu S, Ge M, Sun W-F, Zhao J-Y, Aisa HA, Li Y-H, Jiang J-D (2016) Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response. Free Radical Bio Med 96:347\u2013361. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.04.021","journal-title":"Free Radical Bio Med"},{"issue":"5732","key":"9840_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0140-6736(00)78541-2","volume":"222","author":"W Smith","year":"1933","unstructured":"Smith W, Andrewes CH, Laidlaw PP (1933) A virus obtained from influenza patients. Lancet 222(5732):66\u201368. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(00)78541-2","journal-title":"Lancet"},{"issue":"2392","key":"9840_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.92.2392.405","volume":"92","author":"T Francis","year":"1940","unstructured":"Francis T (1940) A new type of virus from epidemic influenza. Science 92(2392):405\u2013408. \n                    https:\/\/doi.org\/10.1126\/science.92.2392.405","journal-title":"Science"},{"issue":"7583","key":"9840_CR19","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/S0140-6736(68)92683-4","volume":"292","author":"M Coleman","year":"1968","unstructured":"Coleman M, Dowdle W, Pereira H, Schild G, Chang WK (1968) The Hong Kong\/68 influenza A2 variant. Lancet 292(7583):1384\u20131386. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(68)92683-4","journal-title":"Lancet"},{"issue":"6996","key":"9840_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature02746","volume":"430","author":"KS Li","year":"2004","unstructured":"Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, Rahardjo AP, Puthavathana P, Buranathai C, Nguyen TD, Estoepangestie AT, Chaisingh A, Auewarakul P, Long HT, Hanh NT, Webby RJ, Poon LL, Chen H, Shortridge KF, Yuen KY, Webster RG, Peiris JS (2004) Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430(6996):209\u2013213. \n                    https:\/\/doi.org\/10.1038\/nature02746","journal-title":"Nature"},{"issue":"7","key":"9840_CR21","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1086\/511989","volume":"195","author":"DM Morens","year":"2007","unstructured":"Morens DM, Fauci AS (2007) The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 195(7):1018\u20131028. \n                    https:\/\/doi.org\/10.1086\/511989","journal-title":"J Infect Dis"},{"issue":"4","key":"9840_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1080\/21645515.2015.1111494","volume":"12","author":"M Tafalla","year":"2016","unstructured":"Tafalla M, Buijssen M, Geets R, Vonk Noordegraaf-Schouten M (2016) A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countries. Hum Vaccin Immunother 12(4):993\u20131002. \n                    https:\/\/doi.org\/10.1080\/21645515.2015.1111494","journal-title":"Hum Vaccin Immunother"},{"issue":"3620","key":"9840_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.144.3620.862","volume":"144","author":"WL Davies","year":"1964","unstructured":"Davies WL, Grunert RR, Haff RF, McGahen JW, Neumayer EM, Paulshock M, Watts JC, Wood TR, Hermann EC, Hoffmann CE (1964) Antiviral activity of 1-adamantanamine (amantadine). Science 144(3620):862\u2013863. \n                    https:\/\/doi.org\/10.1126\/science.144.3620.862","journal-title":"Science"},{"key":"9840_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/363418a0","volume":"363","author":"M Itzstein von","year":"1993","unstructured":"von Itzstein M, Wu W-Y, Kok GB, Pegg MS, Dyason JC, Jin B, Van Phan T, Smythe ML, White HF, Oliver SW, Colman PM, Varghese JN, Ryan DM, Woods JM, Bethell RC, Hotham VJ, Cameron JM, Penn CR (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418. \n                    https:\/\/doi.org\/10.1038\/363418a0","journal-title":"Nature"},{"issue":"19","key":"9840_CR25","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1021\/jm0002679","volume":"43","author":"YS Babu","year":"2000","unstructured":"Babu YS, Chand P, Bantia S, Kotian P, Dehghani A, El-Kattan Y, Lin T-H, Hutchison TL, Elliott AJ, Parker CD, Ananth SL, Horn LL, Laver GW, Montgomery JA (2000) BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem 43(19):3482\u20133486. \n                    https:\/\/doi.org\/10.1021\/jm0002679","journal-title":"J Med Chem"},{"issue":"2","key":"9840_CR26","doi-asserted-by":"publisher","first-page":"ii5","DOI":"10.1093\/jac\/dkq015","volume":"65","author":"BE Davies","year":"2010","unstructured":"Davies BE (2010) Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations. J Antimicrob Chemoth 65(2):ii5\u2013ii10. \n                    https:\/\/doi.org\/10.1093\/jac\/dkq015","journal-title":"J Antimicrob Chemoth"},{"key":"9840_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ejmech.2016.01.005","volume":"110","author":"H Wang","year":"2016","unstructured":"Wang H, Xu R, Shi Y, Si L, Jiao P, Fan Z, Han X, Wu X, Zhou X, Yu F, Zhang Y, Zhang L, Zhang L, Zhou D, Xiao S (2016) Design, synthesis and biological evaluation of novel l-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors. Eur J Med Chem 110:376\u2013388. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2016.01.005","journal-title":"Eur J Med Chem"},{"issue":"9","key":"9840_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0040-4039(01)84430-0","volume":"13","author":"J Grundy","year":"1972","unstructured":"Grundy J, James BG, Pattenden G (1972) Esterification of sterically hindered carboxylic acids using dimethyl sulphate. Tetrahedron Lett 13(9):757\u2013758. \n                    https:\/\/doi.org\/10.1016\/S0040-4039(01)84430-0","journal-title":"Tetrahedron Lett"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-018-9840-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-018-9840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-018-9840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T05:42:41Z","timestamp":1569044561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-018-9840-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["9840"],"URL":"https:\/\/doi.org\/10.1007\/s11030-018-9840-5","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}